Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.50 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.50 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.50 |
| ▸ | ELANE | P08246 | 1/20 | 0.50 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 4/20 | 0.45 |
| ▸ | CA2 | P00918 | 4/20 | 0.45 |
| ▸ | CA9 | Q16790 | 3/20 | 0.45 |
| ▸ | CA5A | P35218 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | MMP13 | P45452 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | LOX | P28300 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9309031 | 0.88 | KMT2A (0.61) | KMT2APRSS1PRSS2PRSS3FAAH | |
| SCHEMBL8746194 | 0.85 | KMT2A (0.53) | KMT2APRSS1PRSS2PRSS3FAAH | |
| SCHEMBL28223632 | 0.85 | KMT2A (0.53) | KMT2APRSS1PRSS2PRSS3FAAH | |
| SCHEMBL7619550 | 0.84 | KMT2A (0.57) | KMT2APRSS1PRSS2PRSS3FAAH | |
| SCHEMBL6912270 | 0.82 | CA1 (0.63) | KMT2APRSS1PRSS2PRSS3FAAH | |
| SCHEMBL8746110 | 0.81 | KMT2A (0.50) | KMT2APRSS1PRSS2PRSS3FAAH | |
| SCHEMBL29482067 | 0.81 | KMT2A (0.53) | KMT2APRSS1PRSS2PRSS3FAAH | |
| SCHEMBL2383968 | 0.81 | KMT2A (0.53) | KMT2APRSS1PRSS2PRSS3FAAH | |
| SCHEMBL2762566 | 0.81 | KMT2A (0.53) | KMT2APRSS1PRSS2PRSS3FAAH | |
| SCHEMBL8746236 | 0.80 | KMT2A (0.49) | KMT2APRSS1PRSS2PRSS3FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118743770-A | Positron Emission Tomography (PET) radiotracer for imaging macrophage colony stimulating factor 1 receptor (CSF 1R) in neuroinflammation | 约翰霍普金斯大学 | 2024-10-08 | — | — | CN | disclosed |
| EP-3643707-B1 | 18F-LABELLED COMPOUND FOR PROSTATE CANCER DIAGNOSIS, AND USE THEREOF | FUTURECHEM CO LTD (KR) | 2022-02-23 | — | — | EP | disclosed |
| US-10870629-B2 | 18F-labelled compound for prostate cancer diagnosis, and use thereof | FUTURECHEM CO., LTD. (KR) | 2020-12-22 | — | — | US | disclosed |
| US-20200207724-A1 | 18F-LABELLED COMPOUND FOR PROSTATE CANCER DIAGNOSIS, AND USE THEREOF | FUTURECHEM CO., LTD. (KR) | 2020-07-02 | — | — | US | disclosed |
| EP-3643707-A1 | 18F-LABELLED COMPOUND FOR PROSTATE CANCER DIAGNOSIS, AND USE THEREOF | Futurechem Co., Ltd. (KR) | 2020-04-29 | — | — | EP | disclosed |
| CN-102600488-B | IMAGING THE CENTRAL NERVOUS SYSTEM | GE HEALTHCARE LTD | 2013-11-20 | — | — | CN | disclosed |
| CN-102600487-B | Imaging the central nervous system | GE HEALTHCARE LTD | 2013-11-20 | — | — | CN | disclosed |
| EP-1961750-B1 | VLA-4 INHIBITORY DRUG | DAIICHI SANKYO CO LTD (JP) | 2013-09-18 | — | — | EP | disclosed |
| US-20130065882-A1 | VLA-4 inhibitory drug | MACHINAGA NOBUO (JP) | 2013-03-14 | — | — | US | disclosed |
| CN-102600488-A | IMAGING THE CENTRAL NERVOUS SYSTEM | GE HEALTHCARE LTD | 2012-07-25 | — | — | CN | disclosed |
| CN-101970017-B | Visualization of the central nervous system | GE HEALTHCARE LTD | 2012-05-23 | — | — | CN | disclosed |
| US-8129366-B2 | VLA-4 inhibitory drug | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-03-06 | — | — | US | disclosed |
| EP-1697311-B1 | NITRILE COMPOUND AND ITS USE IN PEST CONTROL | SUMITOMO CHEMICAL CO (JP) | 2011-10-26 | — | — | EP | disclosed |
| CN-101970017-A | Visualization of the central nervous system | GE HEALTHCARE LTD | 2011-02-09 | — | — | CN | disclosed |
| US-7662402-B2 | contains fluoroalkyl group; insecticides, miticides, nematocides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-02-16 | — | — | US | disclosed |
| US-20090233901-A1 | VLA-4 INHIBITORY DRUG | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2009-09-17 | — | — | US | disclosed |
| EP-1961750-A1 | VLA-4 INHIBITORY DRUG | Daiichi Sankyo Company, Limited (JP) | 2008-08-27 | — | — | EP | disclosed |
| US-20070112068-A1 | Nitrile compound and its use in pest control | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-05-17 | — | — | US | disclosed |
| EP-1697311-A1 | NITRILE COMPOUND AND ITS USE IN PEST CONTROL | Sumitomo Chemical Company, Limited (JP) | 2006-09-06 | — | — | EP | disclosed |
| WO-2005063694-A1 | NITRILE COMPOUND AND ITS USE IN PEST CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-07-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200207724-A1 | 18F-LABELLED COMPOUND FOR PROSTATE CANCER DIAGNOSIS, AND USE THEREOF | KLK3, FOLH1, AR | KMT2A 1154/4885PRSS1 932/4885PRSS2 2171/4885 |
| US-10870629-B2 | 18F-labelled compound for prostate cancer diagnosis, and use thereof | KLK3, FOLH1, AR | KMT2A 1154/4885PRSS1 932/4885PRSS2 2171/4885 |
| US-20130065882-A1 | VLA-4 inhibitory drug | VCAM1, ITGB4, ITGA4 | KMT2A 656/4885PRSS1 1908/4885PRSS2 3518/4885 |
| US-20070112068-A1 | Nitrile compound and its use in pest control | C5, C9, C1S | KMT2A 2002/4885PRSS1 3501/4885PRSS2 3806/4885 |
| US-20090233901-A1 | VLA-4 INHIBITORY DRUG | VCAM1, ITGB4, ITGA4 | KMT2A 881/4885PRSS1 1464/4885PRSS2 2970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.